Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G/A for COLLEGIUM PHARMACEUTICAL, INC Common Stock (COLL).
- Disclosed ownership: 16%.
- Date of event: 31 Mar 2025.
BlackRock, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for COLLEGIUM PHARMACEUTICAL, INC Common Stock (COLL)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Symbol
- COLL
- Shares outstanding
- 32,037,353 shares
- Disclosed Ownership
- 4,997,827 shares
- Ownership
- 16%
- Form type
- SCHEDULE 13G/A
- Filing time
- 28 Apr 2025, 07:56:18 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 16% ownership in COLLEGIUM PHARMACEUTICAL, INC Common Stock (COLL) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 28 Apr 2025, 07:56.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 16% | 4,997,827 | 4,950,130 | 0 | Spencer Fleming | Managing Director |